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INTRODUCTION
Ginseng, the root of Panax ginseng C.A. Meyer, is a well-
known folk medicine and has been used as a tonic for over
2000 yr (1-3). Recently there has been a renewed interest in
investigating ginseng-pharmacology using biochemical and
molecular biology techniques (2). 
Pharmacological effects of ginseng have been demonstrated
in the central nervous, cardiovascular, endocrine, and immune
systems (1-3). In addition, anti-neoplastic, anti-stress, and
antioxidant activity have been ascribed to ginseng and its
constituents (4, 5). Ginsenosides, which are a diverse group
of steroidal saponins and triterpene derivatives containing
sugar moieties, are the main active ingredients of ginseng
with more than 30 ginsenosides isolated from the roots of
Panax ginseng (1, 2). 
Recognition that delayed biochemical reactions contribute
substantially to tissue damage after head injury has led to the
development of targeted neuroprotective strategies in order to
limit such secondary posttraumatic cell death and to improve
neurological recovery (6). 
Previous reports demonstrated the neuroprotective effect
of ginsenosides in vitro but rarely in vivo, especially in head
trauma (1). In the present study, we evaluated whether treat-
ment with ginseng total saponins (GTSs) can decrease hip-
pocampal neuronal loss, cortical contusion volume, and neu-
rological dysfunction following a controlled cortical impact
(CCI) injury.
MATERIALS AND METHODS
Subjects 
Twenty-four adult male Sprague-Dawley rats weighing
200-250 g were used for these experiments. All procedures
were performed in accordance with the guidelines for care
and use of laboratory animals approved by Chung-Ang Uni-
versity’s Institutional Animal Care and Use Committee. Gin-
senosides used in this study were GTSs obtained from the
Korea Tobacco and Ginseng Research Institute (Daejon,
Korea). One hundred grams of ginseng was boiled gently in
1,000 mL of water for 60 min. The extract was then con-
centrated under reduced pressure to obtain a residue. 
Surgical procedures 
The rats were anesthetized initially with ketamine hydro-
chloride (15 mg/kg, i.m.) and the head was fixed in a stereo-
taxic device (Small Animal stereotaxic instrument, David
Kopf instrument, Tujunga, CA, U.S.A.), then maintained by
2% halothane mixed with oxygen and compressed air. After
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Neuroprotective Effect of Ginseng Total Saponins in Experimental
Traumatic Brain Injury
In the present study, we investigated whether ginseng total saponins (GTSs) pro-
tect hippocampal neurons after experimental traumatic brain injury (TBI) in rats. A
moderate-grade TBI was made with the aid of a controlled cortical impact (CCI)
device set at a velocity of 3.0 m/sec, a deformation of 3.0 mm, and a compression
time of 0.2 sec at the right parietal area for adult male Sprague-Dawley rats. Sham-
operated rats that underwent craniectomy without impact served as controls. GTSs
(100 and 200 mg/kg) or saline was injected intraperitoneally into the rats immedi-
ately post-injury. Twenty-four hours after the injury, the rats underwent neurologi-
cal evaluation. Contusion volume and the number of hippocampal neurons were
calculated with apoptosis evaluated by TUNEL staining. 24 hr post-injury, saline-
injected rats showed a significant loss of neuronal cells in the CA2 region of the right
hippocampus (53.4%, p<0.05) and CA3 (34.6%, p<0.05) compared with contralat-
eral hippocampal region, a significant increase in contusion volume (34±8 L),
and significant increase in neurologic deficits compared with the GTSs groups.
Treating rats with GTSs seemed to protect the CCI-induced neuronal loss in the
hippocampus, decrease cortical contusion volume, and improve neurological deficits.
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a 1.5 cm midline skin incision, a 5 mm diameter craniecto-
my was made over the right parietal cortex with an electric
drill. The craniectomy was centered 3 mm lateral to the sagit-
tal suture and 3 mm posterior to the bregma. Great care was
taken to avoid damaging the underlying dura mater during
the drilling and removal of the cranial bone. 
Experimental controlled cortical injury 
Traumatic brain injury (TBI) was performed using the CCI
method as described previously (7). After the small craniec-
tomy, an injury was produced using a CCI device (CAUH-
2). The device consisted of a 4 mm metal impact tip that was
pneumatically driven at a predetermined pneumatic pres-
sure (70 psi), depth (3 mm), and duration of brain deforma-
tion (0.2 sec). The penetration depth of 3.0 mm was able to
produce a moderate cortical impaction. The wound was closed
with 3-0 silk sutures. 
Administration of total saponins 
The rats subjected to CCI injury were divided into three
groups with six rats per group. Intra-peritoneal injections of
GTSs or saline were performed immediately after injury (≤3
min post-injury). Rats in the 100 mg-GTSs, and 200 mg-
GTSs-treated groups received GTSs dissolved in 1.0 mL saline
at a dose of 100 and 200 mg/kg, respectively. Rats in the
saline-treated group received 1.0 mL of saline. The sham-
operated animals (n=6) received neither GTSs nor saline. 
Neurological evaluation 
Neurologic evaluation was performed after the TBI using
the previously described method (8, 9). The neurobehavioral
battery of tests consisted of a rotarod test using the Rota-Rod/
7750 (Ugo Basile, Co., Comerio, Italy), beam-balance per-
formance, and posture reflex test. 
In the rotarod test, rats were placed on an accelerating rota-
rod. The time each rat remained on the rod was registered
automatically. Neurologic deficit was estimated to be the
time at which the rat could no longer remain on the rotarod
at a speed of 40 rpm, up to 420 sec. If the rat remained on
the rod longer, the test was completed and scored as 420 sec.
Vestibular function was evaluated based on beam-balance
performance. Rats were placed on the beam with their head
away from the wall, and allowed to remain for 60 sec. Each
rat was given three trials, and a mean score was determined. 
The posture reflex test evaluated movement asymmetry
of the forelimbs as the rat was suspended by the base of the
tail. Normal posture was determined to be the symmetrical
reaching of both forelimbs toward the ground and was given
a score of 3. Moderately abnormal posture, which was the
flexion of the contralateral forelimb toward the body, was
given score of 2. Severely impaired posture, characterized by
flexion of the forelimb and rotation of the shoulder and/or
body, was given a score of 1.
Neurological assessments were evaluated 24 hr before and
after TBI by an investigator blinded to the study groups. 
Extraction of the brain 
After neurological evaluation, the rats were anesthetized
again with halothane and the brains were removed from the
calvarium and weighed. There was an identifiable focal cor-
tical injury at the right parietal cortical area. The brain was
cut into 2 mm-thick slices with a rat brain matrix (Harvard
Bioscience Co., Holliston, MA, U.S.A.), and stained with
2% 2,3,5-triphenyl tetrazolium chloride (TTC, Sigma, Inc.,
St. Louis, MO, U.S.A.) at 37℃ for 10 min. After staining,
tissue slices were fixed with 4% buffered paraformaldehyde. 
Contusion volume 
The injury volume was calculated with a digital camera
and an image analyzer program (OPTIMAS 6.5, Optimas,
Inc., Bothell, WA, U.S.A.). 
Histopathological study 
The brain slices at the maximum injury site were made
into paraffin-blocks. The prepared brain sections were cut
into 5  m-thick slices for hematoxylin and eosin (H-E) stain-
ing. Neuronal cells were counted in the hippocampal regions
of CA1, CA2, and CA3 by a pathologist blinded to the study
groups. For each rat, the mean number of neuronal cells was
obtained by examining at least three serial coronal sections
in the hippocampus underlying the area of contusion. In each
section, neurons were counted in three non-overlapping fields
under a high magnification (×400) light microscope in each
sub-region (CA1, CA2, and CA3). Only complete neuronal
cells with a clearly defined cell body and nucleus were counted.
Apoptosis staining 
TUNEL (TdT-mediated dUTP-biotin nick end-labeling)
staining was performed using previously described methods
(10), and was carried out using the TACS2 TDT-DAB kit
(Trevigen, Inc, Gaithersburg, MD, U.S.A.). TUNEL stained
cells were counted under a high magnification (×400) light
microscope. 
Statistical methods 
Neurological scores (Table 1), contusion volume (Table 2),
and neuronal cell counts (Table 3) were presented as mean
scores±SD of the six rats per group. Data was compared
between groups using one-way analysis of variance (ANOVA)
followed by a Tukey-Kramer multiple-comparisons method.Neuroprotective Effect of GTSs 293
Pvalues of <0.05 were considered statistically significant. 
RESULTS
Neurobehavioral assessment 
24 hr after CCI injury, injured rats showed significant neu-
rological deficits compared with the sham-operated rats. CCI
injury led to definite impairments on all neurological func-
tion tests in saline-treated rats compared with the sham-oper-
ated rats (Table 1). The results of the rotarod test, beam bal-
ance performance test, and posture reflex test for saline-treat-
ed rats were 116.5±30.5 sec, 50.0±9.2 sec, and 1.8±0.4,
respectively (Table 1). In rats treated with GTSs (100 or 200
mg/kg) after the CCI injury, neurological deficits were im-
proved significantly compared to saline-treated rats (Table 1).
Rotarod test results for the 100 and 200 mg-GTSs-treated
groups were 165.0±43.7 sec, and 251.2±53.0 sec respec-
tively. The 200 mg-GTSs-treated rats showed a definite im-
provement in the rotarod test compared to saline-treated rats
(p<0.05). Beam-balance performance and posture reflex test
showed no significant difference between groups (p>0.05)
(Table 1). Sham-operated rats did not show any neurological
deficits. 
Contusion volume 
Contusion area was easily defined with 2% TTC staining
in all injured rats (Fig. 1). Contusion volumes in the saline-
treated group, 100 mg-GTSs, and 200 mg-GTSs-treated
group were 32.5±3.5 L,  26.5±2.9  L, and 19.5±2.7 L,
respectively. Treatment with GTSs (100 or 200 mg/kg) sig-
nificantly reduced the contusion volume by 18.5% in the
100 mg-GTSs-treated rats and 40% in the 200 mg-GTSs-
treated rats relative to saline-treated rats (Table 2) (p<0.05).
The effect of GTSs on contusion volume was increased in a
dose-dependent fashion (Fig. 2). Sham-operated rats did not
show any cortical lesion under 2% TTC staining. 
Histopathological outcome 
In the saline-treated rats, CCI injury caused significant
neuronal loss after 24 hr in the CA2 (53.4%, p<0.05) and
CA3 (34.6%, p<0.05) regions of the hippocampus (Fig. 3A,
C) compared to the results from contralateral hippocampal
Fig. 1. Photographs showing the morphological features of CCI-
induced brain injury. The extent of contusion is greatest in the
saline-treated group (A). The contusion volume in the saline-treat-
ed group, 100 mg-GTSs-treated group (B), 200 mg-GTSs-treated
group (C) were 32.5±3.5 L,  26.5±2.9  L, and 19.5±2.7 L
respectively. The effect of GTSs on brain contusion was increased
in a dose-dependent fashion. CCI, controlled cortical impact; GTSs,
ginseng total saponins.
*All data are presented as the mean±standard deviations. 
� p<0.05.
GTSs, ginseng total saponins; Pre, preoperative; Post, postoperative.
Posture
reflex score
Beam-balance
(sec)
Rotarod (sec)
Pre Post Pre Post Pre Post
Saline-treated group 420 116.5±30.5 60 50.0±9.2 3 1.8±0.4
100 mg-GTSs-treated 420 165.0±43.7 60 51.8±7.8 3 2.0±0.6
group
200 mg-GTSs-treated 420 251.2±53.0
� 60 55.0±5.6 3 2.3±0.5
group
Table 1. Neurologic assessments after traumatic brain injury*
*percentage of relative volume compared with mean contusion volume
of saline-treated group. 
� p<0.05, compared with saline-treated group.
� p<0.05, compared with 100 mg-GTSs-treated group.
GTSs, ginseng total saponins.
Contusion volume
(L )
Percentage of contusion
volume (%)*
Saline-treated group 32.5±3.5 100
100 mg-GTSs group 26.5±2.9
� 81.5
200 mg-GTSs group 19.5±2.7
� 60
Table 2. Contusion volume after traumatic brain injury
*p<0.05, compared with saline-treated group. 
� p<0.05, compared with 100 mg-GTSs-treated group. CA, cornu ammonis; GTSs, ginseng total saponins. 
CA3 CA2 CA1
Ipsilateral Contralateral Ipsilateral Contralateral Ipsilateral Contralateral
Saline-treated group 50.3±3.9 59.7±5.2 33.8±4.2 72.5±6.6 43.5±5.0 66.5±6.1
100 mg-GTSs-treated group 55.3±3.7 62.5±6.8 51.2±2.9* 66.1±6.4 49.2±3.8* 64.8±4.3
200 mg-GTSs-treated group 57.3±3.1 63.3±5.5 55.8±2.6
� 66.5±6.6 55.3±1.5
� 64.2±4.5
Table 3. Number of neuronal cells in hippocampus after TBI
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region (Fig. 3B, D) (Table 3). Treating rats with GTSs at a
dose of 100 mg/kg showed significant decrease of the TBI-
induced neuronal loss in the CA2 (22.7%, p<0.05) and CA3
(24.1%, p<0.05) regions relative to contralateral lesions (Table
3). 200 mg/kg GTSs dosage also showed significant TBI-
induced neuronal loss decrease in the CA2 (16.1%, p<0.05)
and CA3 (13.9%, p<0.05) regions (Fig. 3E, G) (Table 3). The
protective effect of GTSs on hippocampal cell death was in-
creased in a dose-dependent fashion (Table 3). There was no
significant difference between groups in the CA1 region (Table
3) (p>0.05). 
TUNEL staining 
TUNEL-positive cells were found in the pericontusional
zone in all injured groups. TUNEL-positive cells were not
found in the contralateral cortex or in the contralateral hip-
pocampal area. The number of TUNEL-positive cells was
11.5±1.9 cells/HPF in the saline-treated rats, 10.8±1.5
cells/HPF in the 100 mg-GTSs-treated rats, and 10.3±1.8
cells/HPF in the 200 mg-GTSs-treated rats. There was no
significant difference in the number of TUNEL-positive cells
between groups (p>0.05). There were no TUNEL-positive
cells in the sham-operated group.
DISCUSSION
In general, TBI mechanisms include changes in ionic home-
ostasis (such as calcium, potassium, sodium, and magnesium),
release of excitatory amino acids, induction of free radicals,
inflammatory/immune changes, and alterations of multiple
neurotransmitter systems (11). It is also known that TBI leads
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Fig. 2. Bar graph showing that GTSs significantly decreased the
volume of CCI-induced cortical contusion compared with the saline
treated group. Saline; saline-treated group, 100-GTSs; 100 mg-
GTSs-treated group, 200-GTSs; 200 mg-GTSs-treated group. CCI,
controlled cortical impact; GTSs, ginseng total saponins. 
*p<0.05, compared with saline-treated group.
**p<0.05, compared with 100 mg-GTSs-treated group.
Fig. 3. Photomicrographs showing the ipsilateral (A, C, E, G) and contralateral (B, D, F, H) hippocampus of rats subjected to CCI injury;
saline-treated group (A to D), and 200 mg-GTSs-treated group (E to H). In the saline-treated group, there was a significant neuronal loss
in the CA2 and CA3 regions compared with the intact hippocampus. The treatment with GTSs significantly prevented CCI-induced neu-
ronal loss in the ipsilateral CA2 and CA3 regions compared with saline-treated group. Original magnification ×40 (upper panels) and ×100
(lower panels). H&E. CA, cornu ammonis; CCI, controlled cortical impact.
A B E F
C D G Hto apoptotic and necrotic cell death, but both cell death forms
may be pharmacologically modulated (12). 
The CCI model can produce graded, reproducible, and
quantifiable brain injury in rats (13-15). The severity of the
CCI injury in rats was defined by measuring the pathologi-
cal effects of varying compression and impact velocity (16).
Cortical injury, hippocampal neuron loss, and neurological
deficits were found to be produced by moderate-grade CCI
injury (15). We created a 3.0 mm deformation by applying
a 3.0 m/sec velocity, which corresponds to a moderate grade
of injury. We restricted studies to moderate injury because
severe-grade CCI produces extensive brain damage result-
ing in a high mortality rate. 
In this study, data demonstrated that the rotarod test was
superior to the beam-balance or posture reflex tests in reliably
detecting motor dysfunction differences between groups. Our
results were in accordance with a previous study (17). 
Previous authors had used TTC staining for quantification
of infarction volume after focal cerebral ischemia. Further-
more, TTC has been utilized to assess the effectiveness of
potential neuroprotective agents (16). Because moderately
severe CCI-induced brain injury may result in penetration,
causing a tear in the dura and a significant swelling of the
brain, the cortical injury after TBI usually results in a com-
plex shape and indistinct border, making contusion volume
measurement difficult (16). We made 2 mm-thick brain slices
to measure precise injured volume, and a relatively well-demar-
cated contusion area could be confirmed. This seemed to be
an adequate thickness for contusion area definition and the
measurement of contusion volume. 
GTSs are a mixture of ginsenosides with various ginseno-
side ratios as follows: Rb1, 18.26%; Rb2, 9.07%; Rc, 9.65%;
Rd, 8.24%; Re, 9.28%; Rf, 3.48%; Rg1, 6.42%; Rg2, 3.63%;
Rh1, 4.70%; R0, 3.82%; Ra, 2.91%; and other minor gin-
senosides (1). We observed that GTSs effectively improved
neurological recovery following moderate CCI injury. Although
the molecular mechanisms of neuroprotection in TBI by gin-
senosides are not clear, there are several potential mechanisms.
It is possible that ginsenosides may act as antioxidants, or
free radical scavengers (18). It is well established that lipid
peroxidation by free radicals is one of a number of biological
mechanisms responsible for secondary injury after traumatic
or ischemic injury to the CNS (11).
Ginsenosides may possess the ability to protect neurons
from ischemic damage, and were shown to rescue hippocam-
pal neurons from lethal ischemic damage possibly by scaveng-
ing free radicals, which are overproduced in situ after brain
ischemia and reperfusion (19, 20). Another study described
that the antioxidant action of ginsenosides was based on the
chemical structure of ginsenoside Rb1 similar to that of 21-
aminosteroids (19). It also binds to glucocorticoid receptor
with specific affinity and triggers transcriptional activation of
glucocorticoid response elements-containing receptor plas-
mids (21). It promotes cell proliferation and enhances the
survival rate of new-born cells (20). 
We could not find a difference in the number of TUNEL-
positive cells between groups. Previous studies describe that
ginsenosides induce (22) or inhibit apoptotic cell death
(23). Further studies are needed to evaluate the effect of gin-
senosides on apoptosis relating to the TBI. 
This study suggests for the first time that ginsenosides show
a neuroprotective effect after experimental traumatic brain
injury. However, because this study reflected effects of GTSs
at 24 hr after traumatic brain injury, we could not define the
time of maximal effect and duration of action. Further stud-
ies are needed to evaluate the effects of individual ginseno-
sides in TBI. 
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